2021 临床实践指南:儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防

2021-07-09 国外肿瘤科相关专家小组(统称) Eur J Cancer.2021 Jul 9;154:92-101.

本文是对2015年儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防指南的更新,最终共形成了6条推荐意见。

中文标题:

2021 临床实践指南:儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防

英文标题:

Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update

发布日期:

2021-07-09

简要介绍:

本文是对2015年儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防指南的更新,最终共形成了6条推荐意见。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 临床实践指南:儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d97541c002135296, title=2021 临床实践指南:儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防, enTitle=Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update, guiderFrom=Eur J Cancer.2021 Jul 9;154:92-101., authorId=0, author=, summary=本文是对2015年儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防指南的更新,最终共形成了6条推荐意见。, cover=https://img.medsci.cn/2021724/1627128093508_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Fri Jul 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>本文是对2015年儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防指南的更新,最终共形成了6条推荐意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=8486, tagName=造血干细胞移植)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8486, guiderKeyword=造血干细胞移植, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10380, appHits=119, showAppHits=0, pcHits=521, showPcHits=10261, likes=0, shares=15, comments=3, approvalStatus=1, publishedTime=Sat Jul 24 21:38:12 CST 2021, publishedTimeString=2021-07-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 24 20:01:43 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Wed Jan 03 11:00:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 临床实践指南:儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防.pdf)])
2021 临床实践指南:儿童肿瘤及造血干细胞移植患者口腔及口咽黏膜炎的预防.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066759, encodeId=92f01066e5936, content=太有价值了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Nov 04 04:10:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065406, encodeId=d15f106540692, content=很好很及时的一篇文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Sun Oct 31 01:30:41 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002732, encodeId=22641002e32a9, content=很有意义,就是看不了呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Mon Jul 26 13:38:07 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
    2021-11-04 RENYUQIONG200798

    太有价值了!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066759, encodeId=92f01066e5936, content=太有价值了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Nov 04 04:10:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065406, encodeId=d15f106540692, content=很好很及时的一篇文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Sun Oct 31 01:30:41 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002732, encodeId=22641002e32a9, content=很有意义,就是看不了呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Mon Jul 26 13:38:07 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
    2021-10-31 RENYUQIONG200798

    很好很及时的一篇文章!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066759, encodeId=92f01066e5936, content=太有价值了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Nov 04 04:10:02 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065406, encodeId=d15f106540692, content=很好很及时的一篇文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Sun Oct 31 01:30:41 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002732, encodeId=22641002e32a9, content=很有意义,就是看不了呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Mon Jul 26 13:38:07 CST 2021, time=2021-07-26, status=1, ipAttribution=)]
    2021-07-26 ms9000000105540481

    很有意义,就是看不了呀

    0

拓展阅读

2015 ASBMT指南:造血干细胞移植治疗多发性骨髓瘤

美国血液与骨髓移植学会(ASBMT,American Society for Blood and Marrow Transplantation) · 2015-03-10

2016 ECIL-5建议:血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2016-05-01

2018 EBMT立场声明:造血干细胞移植后患者腺病毒感染的管理

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2018-04-16